Cargando…
Clinical perspectives, assessment, and mechanisms of metabolic-associated fatty liver disease in patients with COVID-19
Metabolic diseases are highly prevalent worldwide and have been associated with adverse clinical outcomes, including mortality, in patients developing coronavirus disease (COVID-19). Because of the close relationship between metabolic diseases such as type 2 diabetes mellitus and obesity and the pre...
Autores principales: | Campos-Murguía, Alejandro, Román-Calleja, Berenice M, González-Regueiro, José A, Hurtado-Díaz-de-León, Ivonne, Solís-Ortega, Alberto Adrián, Flores-García, Nayelli C, García-Juárez, Ignacio, Ruiz-Margáin, Astrid, Macías-Rodríguez, Ricardo Ulises |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Baishideng Publishing Group Inc
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8433612/ https://www.ncbi.nlm.nih.gov/pubmed/34588748 http://dx.doi.org/10.3748/wjg.v27.i33.5502 |
Ejemplares similares
-
Nutritional therapy for hepatocellular carcinoma
por: Ruiz-Margáin, Astrid, et al.
Publicado: (2021) -
Reply to: “Liver fibrosis and adverse outcomes in COVID-19”
por: Ruiz-Margáin, Astrid, et al.
Publicado: (2021) -
Clinical assessment and management of liver fibrosis in non-alcoholic fatty liver disease
por: Campos-Murguía, Alejandro, et al.
Publicado: (2020) -
Prognostic performance of an index based on lactic dehydrogenase and transaminases for patients with liver steatosis and COVID-19
por: Macías-Rodríguez, Ricardo Ulises, et al.
Publicado: (2022) -
Myostatin is associated with the presence and development of acute-on-chronic liver failure
por: Ruiz-Margáin, Astrid, et al.
Publicado: (2023)